Comparison of gene expression profiles in tubulocystic carcinoma and collecting duct carcinoma of the kidney

American Journal of Surgical Pathology

Volumn 33, Issue 7, 2009, Pages 1103-1106

  Osunkoya, Adeboye O ^a,b   Young, Andrew N ^a   Wang, Wenle ^c   Netto, George J ^d,e   Epstein, Jonathan I ^d,e  

^a The Departments of Pathology   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d Departments of Pathology   (United States)

^e JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Collecting duct carcinoma; Gene expression profiles; Tubulocystic carcinoma

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN 19; CYTOKERATIN 7; PARVALBUMIN; PROTEIN P53; UVOMORULIN; VIMENTIN;

ARTICLE; BELLINI DUCT CARCINOMA; CLINICAL ARTICLE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY COLLECTING DUCT CARCINOMA; KIDNEY COLLECTING TUBULE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; TUBULOCYSTIC CARCINOMA;

CARCINOMA, RENAL CELL; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; KIDNEY NEOPLASMS; KIDNEY TUBULES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 67149099650     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181a13e7b     Document Type: Article

References (20)

1. Amin MB, Varma M, Tickoo S, et al. Collecting duct carcinoma of kidney-a review. Adv Anat Pathol. 1997;4:85-94.
2. Amin MB, MacLennan GT, Paraf F, et al. Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 29 cases of a distinctive rare subtype of renal carcinoma. Mod Pathol. 2004;17(suppl):137A.
3. Amin MB, Maclennan GT, Gupta R, et al. Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma. Am J Surg Pathol. 2008; 33:384-392.
4. Azoulay S, Vieillefond A, Paraf F, et al. Tubulocystic carcinoma of the kidney: a new entity among renal tumors. Virchows Arch. 2007;451:905-909.
5. Eble JN, Sauter G, Epstein JI, et al. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs. Lyon: IARC Press; 2004.
6. Gü rocak S, Sozen S, Akyurek N, et al. Cortically located collecting duct carcinoma. Urology. 2005;65:1226.
7. Higgins JP, Shinghal R, Gill H, et al. Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am J Pathol. 2003;162:925-932.
8. Kennedy SM, Merino MJ, Linehan WM, et al. Collecting duct carcinoma of the kidney. Hum Pathol. 1990;21:449-456.
9. MacLennan GT, Bostwick DG. Tubulocystic carcinoma, mucinous tubular and spindle cell carcinoma, and other recently described rare renal tumors. Clin Lab Med. 2005;25:393-416.
10. MacLennan GT, Farrow GM, Bostwick DG. Low-grade collecting duct carcinoma of the kidney: report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct origin. Urology. 1997;50:679-684.
11. Murphy W, Grignon D, Perlman E. Tumors of the Ureters and the Renal Pelvis. AFIP Atlas of Tumor Pathology: Tumors of the Kidney, Bladder and Related Urinary Structures. Washington DC: American Registry of Pathology; 2004:375-382.
12. Rohan S, Tu JJ, Kao J, et al. Gene expression profiling separates chromophobe renal cell carcinoma from oncocytoma and identifies vesicular transport and cell junction proteins as differentially expressed genes. Clin Cancer Res. 2006;12:6937-6945.
13. Schuetz AN, Yin-Goen Q, Amin MB, et al. Molecular classification of renal tumors by gene expression profiling. J Mol Diagn. 2005; 7:206-218.
14. Srigley JR, Eble JN. Collecting duct carcinoma of kidney. Semin Diagn Pathol. 1998;15:54-67.
15. Takahashi M, Sugimura J, Yang X, et al. Gene expression profiling of renal cell carcinoma and its implications in diagnosis, prognosis, and therapeutics. Adv Cancer Res. 2003;89:157-181.
16. Yang XJ, Sugimura J, Schafernak KT, et al. Classification of renal neoplasms based on molecular signatures. J Urol. 2006;175: 2302-2306.
17. Yang XJ, Zhou M, Hes O, et al. Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization. Am J Surg Pathol. 2008;32:177-187.
18. Young AN, Amin MB, Moreno CS, et al. Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am J Pathol. 2001;158: 1639-1651.
19. Young AN, de Oliveira Salles PG, Lim SD, et al. Beta defensin, parvalbumin, and vimentin: a panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDNA microarrays. Am J Surg Pathol. 2003; 27:199-205.
20. Young AN, Master VA, Paner GP, et al. Renal epithelial neoplasms: diagnostic applications of gene expression profiling. Adv Anat Pathol. 2008;15:28-38.